|
Coco is a highly-regarded entrepreneur with an exemplary track record of technical innovation, corporate leadership and value-building. He has been a widely recognized leader in the laser scanning industry since its inception in the 1960s. He is named inventor on forty issued patents including several of the most basic patents in galvonometry. In 1997, Mr. Montagu founded Genetic MicroSystems (GMS), which was subsequently acquired by Affymetrix. At Affymetrix, he served as Vice President of Advanced Technology until 2000. Prior to founding GMS, Mr. Montagu was founder and Chairman of General Scanning, Inc. (GSI), the world leader in laser scanning galvonometers. During his tenure, GSI grew into a laser systems provider with annual revenues of $180M. Prior to GSI, Mr. Montagu founded MFE, Inc., which became a leader in strip chart recorders for the medical industry.
Roger is a general manager with more than twenty years of product and business development experience in the laser scanning, life science and medical industries. He holds a B.S. in Electrical Engineering from Northeastern University and is named inventor on six issued patents. Starting in 1985, Mr. Dowd held several positions at General Scanning Inc. (GSI) including General Manager of the Life Sciences Business Unit. In that position, he led the transformation of an advanced engineering team into a life sciences business, culminating in its sale to Packard BioSciences for $120M. After the merger of GSI and Lumonics and the sale of the life sciences business, Mr. Dowd was recruited to lead the GSI Lumonics memory repair product line, a position that he left in December of 2001.
Joe brings to Decision Biomarkers a track record of more than 20 years of leadership experience in the global life science industry with companies ranging from large multinationals to start-ups. His expertise stems from a strong foundation of senior-level industry experience in corporate development, general management, international business development and sales operations. Prior to joining Decision Biomarkers, Joe was with Altus Pharmaceuticals, now a NASDAQ-listed biopharmaceutical company, where he served as General Manager and Vice President, Business Development & Marketing. As an early member of Altus’ leadership team, he played an instrumental role in building the company and leading its transition from a research-based start-up to a successful development-stage biopharmaceutical firm. Joe also held senior operations and business unit management positions with Genencor International, a leading international life science firm, along with Akzo Chemicals of The Netherlands and DuPont. Joe holds B.S. and M.B.A. degrees from Miami University.
Walter has more than twenty five years experience in product development, including leading teams that developed instrumentation and capital equipment in the medical, life sciences, and semiconductor markets. Prior to joining the company in 2004, he held leadership positions in the Molecular Biology, Spectroscopy, and Vacuum Concentration product development groups of Thermo Electron’s Life and Laboratory Science segment. Prior to joining Thermo, Mr. Leslie held several positions at General Scanning (GSI) including Engineering Manager of a $60M laser engraving equipment line, and Engineering Manager for a $20M medical imaging business unit. Mr. Leslie received B.S. and M.S. degrees in Electrical Engineering from Tufts University.
Peter has more than fifteen years experience in both research and clinical diagnostics in assay development and tumor marker assays at Ciba-Corning, diagnostic assay development, clinical trials and FDA submission at Chiron Diagnostics, and most recently biomarker validation and biomarkers for drug development at Bayer Diagnostics. Dr. Maimonis has presented at numerous national and international scientific conferences and has published many peer-reviewed articles and abstracts on biomarkers. Dr. Maimonis has a B.S. in Biology from MIT and a Ph.D. in Tumor Immunology from Brown University.
[ back to top ] |
